Results for subkut translation from Latvian to English

subkut nai lietošanai.
subcutaneous use

subkut nai vai intravenozai lietošanai.
subcutaneous or intravenous use ro

lietošanas veids subkut nai lietošanai.
administration for subcutaneous use.

insulatard parasti ievada subkut ni augšstilb.
insulatard is administered subcutaneously in the thigh.

velosulin ievada subkut ni v dera priekš j sien.
administered by subcutaneous injection. ed

novomix 30 ievada subkut ni augšstilb vai v dera priekš j sien.
novomix 30 is administered subcutaneously in the thigh or in the abdominal wall.

insulatard ir paredz ts injic šanai zem das (subkut ni).
insulatard is for injection under the skin (subcutaneously).

novomix 50 ir paredz ts injic šanai zem das (subkut ni).
novomix 50 is for injection under the skin (subcutaneously).

lietošanas veids novomix 50 ievada injic jot subkut ni augšstilb vai v dera priekš j sien.
novomix 50 is administered subcutaneously by injection in the thigh or in the abdominal wall.

ja novomix 30 tiek injic ts subkut ni, darb ba s kas 10 l dz 20 min šu laik p c injekcijas.
when novomix 30 is injected subcutaneously, the onset of action will occur within 10 to 20 minutes of injection.

uzs kšan s maksim l koncentr cija plazm tiek sasniegta 1 ½ l dz 2 ½ stundu laik p c subkut nas ievad šanas.
absorption the maximum plasma concentration is reached within 1.5-2.5 hours after subcutaneous administration.

p c subkut nas injekcijas augšstilb uzs kšan s ir l n ka un maz k main ga nek p c ievad šanas cit s injekciju viet s.
subcutaneous injection into the thigh results in a slower and less variable absorption compared to the other injection sites.

uzs kšan s maksim l insul na koncentr cija plazm tiek sasniegta 2 - 18 stundu laik p c subkut nas ievad šanas.
absorption the maximum plasma concentration of the insulin is reached within 2-18 hours after subcutaneous administration.

Šis fosf tu- bufer tais š stošais insul ns ir paredz ts past v gai subkut nai insul na inf zijai (psii) r jos es
this phosphate-buffered soluble insulin is intended for continuous subcutaneous insulin infusion (csii) in external insulin infusion pumps. ro

rē insul na inf zijas (psii) past v gas subkut nas insul na inf zijas (psii) r jos insul na inf zijas s k os parasti ievada v dera
continuous subcutaneous insulin infusion (csii) in external insulin infusion pumps is usually

pacientiem, ievadot velosulin ar psii, ir j b t pieejamai injekciju š ircei un alternat vam insul nam neparedz tam gad jumam vai s k a darb bas p rtraukuma, vai boj juma gad jum, lai var tu ievad t insul nu ar subkut nu injekciju.
if the patient suspects an interruption to insulin flow the patient should notify the health care professional. a in

45 veseliem br vpr t gajiem vid ji maksim l koncentr cija serum 645 ± 185 pmol/ l tika sasniegta apm ram 60 min šu laik p c 0, 30 v/ kg erme a masas devas ievad šanas subkut ni.
in healthy volunteers a mean maximum serum concentration of 645 ± 185 pmol/ l was reached about 60 minutes after a subcutaneous dose of 0.30 u/ kg body weight.